These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Residual risks of blood transfusion in Rhode Island. Sweeney JD; Kurtis J; Starakiewicz J Med Health R I; 2005 Jul; 88(7):224-5, 228-31. PubMed ID: 16184827 [No Abstract] [Full Text] [Related]
4. [Pathogen inactivation processes applicable to cellular products: the Canadian perspective]. Delage G Transfus Clin Biol; 2011 Aug; 18(4):485-7. PubMed ID: 21715210 [TBL] [Abstract][Full Text] [Related]
5. Clinical trials for pathogen reduction in transfusion medicine: a review. McClaskey J; Xu M; Snyder EL; Tormey CA Transfus Apher Sci; 2009 Dec; 41(3):217-25. PubMed ID: 19793679 [TBL] [Abstract][Full Text] [Related]
6. Pathogen Reduction Technology in Transfusion: Where Do We Stand? Khurshid M; Moiz B J Coll Physicians Surg Pak; 2015 Nov; 25(11):779-80. PubMed ID: 26577959 [No Abstract] [Full Text] [Related]
9. [Pathogen inactivation of platelets: organization consequences for platelet transfusion]. Chavarin P; DePutter C; Boussoulade F; Acquart S; Vidal M; Argaud C; Fabrigli P; Garraud O Transfus Clin Biol; 2011 Aug; 18(4):472-7. PubMed ID: 21783400 [TBL] [Abstract][Full Text] [Related]
10. Improving blood safety and patient outcomes with pathogen reduction technology. Goodrich RP; Ettinger A; Radziwon PM; Rock G Transfus Apher Sci; 2011 Dec; 45(3):229-38. PubMed ID: 22078570 [No Abstract] [Full Text] [Related]
11. Pathogen reduction: state of reflection in Ireland. Murphy WG Transfus Clin Biol; 2011 Aug; 18(4):488-90. PubMed ID: 21803629 [TBL] [Abstract][Full Text] [Related]
12. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Blajchman MA Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252 [TBL] [Abstract][Full Text] [Related]
14. [Pathogen inactivation in platelet concentrates: the French experience]. Cazenave JP Transfus Clin Biol; 2011 Aug; 18(4):478-84. PubMed ID: 21719338 [TBL] [Abstract][Full Text] [Related]
15. [Pathogen reduction of blood components: from financial issues to possible long-term consequences]. Canellini G; Wasserfallen JB; Tissot JD Transfus Clin Biol; 2011 Aug; 18(4):493-7. PubMed ID: 21719339 [TBL] [Abstract][Full Text] [Related]
16. Evolution of microbial safety. Barbara JA Hematol J; 2004; 5 Suppl 3():S69-73. PubMed ID: 15190282 [No Abstract] [Full Text] [Related]
17. [The BOTIA project ("Blood and Organ Transmissible Infectious Agents"): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation]. Lefrère JJ Transfus Clin Biol; 2005 Jun; 12(2):93-4. PubMed ID: 15894503 [No Abstract] [Full Text] [Related]